Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maren H Harms

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Gastroenterology|October 23, 2018
Risk stratification and prognostic modelling in primary biliary cholangitisJorn C Goet, Maren H Harms, Marco Carbone, et al.
Best Practice & Research. Clinical Gastroenterology|October 23, 2018
Improving prognosis in primary biliary cholangitis - Therapeutic options and strategyMaren H Harms, Henk R van Buuren, Adriaan J van der Meer
Digestive Diseases (Basel, Switzerland)|December 8, 2015
Surrogate Endpoints for Optimal Therapeutic Response to UDCA in Primary Biliary CholangitisHenk R van Buuren, Willem J Lammers, Maren H Harms, et al.
International Journal of Emergency Medicine|August 7, 2014
Self-referred patients at the Emergency Department: patient characteristics, motivations, and willingness to make a copaymentJanneke de Valk, Elisabeth M Taal, Mariette S Nijhoff, et al.
International Journal of Emergency Medicine|May 19, 2015
Erratum: Self-referred patients at the Emergency Department: patient characteristics, motivations, and willingness to make a copaymentJanneke de Valk, Elisabeth M Taal, Mariette S Nijhoff, et al.
Hepatology Communications|June 9, 2018
Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitisMarco Carbone, Maren H Harms, Willem J Lammers, et al.
JHEP Reports : Innovation in Hepatology|December 15, 2020
Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitisMaren H Harms, Gideon M Hirschfield, Annarosa Floreani, et al.
BMJ Open Gastroenterology|December 17, 2021
Measurement properties of the PBC-40 and PBC-27: a Dutch validation studyRozanne C de Veer, Geraldine da Silva, Maria C van Hooff, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 12, 2023
Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients' perspectives and objective disease parametersRozanne C de Veer, Maria C van Hooff, Geraldine da Silva, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2018
Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decadesMaren H Harms, Quisette P Janssen, Rene Adam, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Gastroenterology|October 23, 2018
Risk stratification and prognostic modelling in primary biliary cholangitisJorn C Goet, Maren H Harms, Marco Carbone, et al.
Best Practice & Research. Clinical Gastroenterology|October 23, 2018
Improving prognosis in primary biliary cholangitis - Therapeutic options and strategyMaren H Harms, Henk R van Buuren, Adriaan J van der Meer
Digestive Diseases (Basel, Switzerland)|December 8, 2015
Surrogate Endpoints for Optimal Therapeutic Response to UDCA in Primary Biliary CholangitisHenk R van Buuren, Willem J Lammers, Maren H Harms, et al.
International Journal of Emergency Medicine|August 7, 2014
Self-referred patients at the Emergency Department: patient characteristics, motivations, and willingness to make a copaymentJanneke de Valk, Elisabeth M Taal, Mariette S Nijhoff, et al.
International Journal of Emergency Medicine|May 19, 2015
Erratum: Self-referred patients at the Emergency Department: patient characteristics, motivations, and willingness to make a copaymentJanneke de Valk, Elisabeth M Taal, Mariette S Nijhoff, et al.
Hepatology Communications|June 9, 2018
Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitisMarco Carbone, Maren H Harms, Willem J Lammers, et al.
JHEP Reports : Innovation in Hepatology|December 15, 2020
Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitisMaren H Harms, Gideon M Hirschfield, Annarosa Floreani, et al.
BMJ Open Gastroenterology|December 17, 2021
Measurement properties of the PBC-40 and PBC-27: a Dutch validation studyRozanne C de Veer, Geraldine da Silva, Maria C van Hooff, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 12, 2023
Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients' perspectives and objective disease parametersRozanne C de Veer, Maria C van Hooff, Geraldine da Silva, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2018
Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decadesMaren H Harms, Quisette P Janssen, Rene Adam, et al.
Pageof 3